A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Clinical trial NCT04501679 · COMPLETED
Trial details
- NCT number
- NCT04501679
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2022-03-30
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.